Scholars Central

Mini reviewPublished 1 Feb 2019

Chelation and Gadolinium: How Effective is it?

Authors: E Blaurock-Busch

Micro Trace Minerals laboratory, Germany

Diagnostic Pathology: Open Access

Volume 4 · Issue 1 · Pages 1–5

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Gadolinium-Based Contrast Agents (GBCA) are intravenous drugs used in diagnostic imaging procedures to enhance the quality of magnetic resonance imaging (MRI) or magnetic resonance angiography (MRA). Recent FDA alerts concerning potential side effects increased patient and medical concerns. We checked if gadolinium remains in the body system longer than pharmaceutical information states and since a growing number of chelation therapists uses chelating agents to remove gadolinium that may have been stored in the body, we checked how effective chelation agents are. Our studies indicate that in the case of gadolinium, chelation does not seem to be an option.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

Similar by topic

More from this journal

The newest in Diagnostic Pathology: Open Access.

All its articles

Conferences in this field

Upcoming conferences in this field.

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalDiagnostic Pathology: Open Access
  • SubjectPathology & Lab Medicine
  • BylineArticles whose byline prints “E Blaurock-Busch”

For authors and organisers

Publish, present and keep up with your field

Find the right journal for your paper and submit your manuscript.

Photo: Pexels